Also trades as: TYHT (NASDAQ) · $vol 2M
SISI OTC
Shineco, Inc.
1W: +0.0%
1M: +34900.0%
3M: -47.5%
YTD: +52400.0%
1Y: -99.7%
3Y: -100.0%
5Y: -100.0%
$0.10
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
34 relationships34
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-06-11
Earliest Filing
2025-06-23
Latest Filing
target: 12
acquirer: 10
partner: 7
investor: 4
supplier: 1
Counterparties (Filed by SISI)
34 relationshipsCompanies named in SISI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| InfiniClone Limited | — | target | Target company acquired by Shineco Life Science Group Hong Kong Co., Limited for 51% equity interests. | 2025-06-23 | View |
| Shineco,Inc | SISI | investor | Parent company of Purchaser issuing shares as consideration | 2025-04-23 | View |
| InfiniClone Limited | — | target | Target company whose shares are being sold | 2025-04-23 | View |
| SHINECO LIFE SCIENCE GROUP HONG KONG CO., LTD. | SISI | acquirer | Purchaser acquiring 51% of InfiniClone Limited | 2025-04-23 | View |
| Shineco Life Science Group Hong Kong Co., Limited | SISI | acquirer | Purchaser acquiring 75% equity in Hong Kong Fuwang International Company Limited | 2025-03-20 | View |
| Shineco, Inc. | SISI | acquirer | Parent company of the Purchaser issuing restricted shares as payment | 2025-03-20 | View |
| Dream Partner Limited | — | acquirer | Hong Kong subsidiary of Shineco, Inc. transferring equity as payment consideration | 2025-03-20 | View |
| FuWang (HK) International Company Limited | — | target | Target company whose equity is being acquired by the Purchaser | 2025-03-20 | View |
| Jiangsu Fuwang Medical Equipment Co., Ltd. | — | target | Target company indirectly controlled by the Hong Kong company and subject to governance adjustments | 2025-03-20 | View |
| SHINECO, INC. | SISI | partner | Company issuing common stock in an underwriting agreement | 2024-07-17 | View |
| EF HUTTON LLC | — | partner | Representative of the several underwriters purchasing shares | 2024-07-17 | View |
| Shineco Life Science Group Hong Kong Co., Limited | SISI | acquirer | Wholly-owned subsidiary of the Parent purchasing equity interests. | 2023-09-21 | View |
| Dream Partner Limited | — | target | Company whose equity interests are being sold in the transaction. | 2023-09-21 | View |
| Shineco, Inc. | SISI | acquirer | Parent company purchasing equity interests and issuing shares to sellers. | 2023-09-21 | View |
| Chongqing Wintus Group | — | partner | Wholly-owned subsidiary of the Company engaged in manufacturing silk products. | 2023-09-21 | View |
| Beijing Tenet-Jove Technological Development Co., Ltd. | — | partner | Wholly-owned subsidiary of the Parent whose equity interest is transferred to sellers. | 2023-09-21 | View |
| Shineco Life Science Research Co., Ltd. | SISI | acquirer | Buyer in the stock purchase agreement | 2023-01-04 | View |
| Beijing Kanghuayuan Medicine Information Consulting Co., Ltd. | — | supplier | Seller in the stock purchase agreement | 2023-01-04 | View |
| Shineco, Inc. | SISI | investor | Parent company of the Buyer issuing restricted shares | 2023-01-04 | View |
| Changzhou Biowin Pharmaceutical Co., Ltd. | — | target | Target company whose equity is being sold | 2023-01-04 | View |
| Shineco, Inc. | SISI | acquirer | Acquiring 51% equity interest in Changzhou Biowin Pharmaceutical Co., Ltd. | 2022-10-25 | View |
| Changzhou Biowin Pharmaceutical Co., Ltd. | — | target | Target of acquisition by Shineco, Inc. for 51% equity interest. | 2022-10-25 | View |
| Weifang Jianyi Medical Devices Co., Ltd. | — | partner | Joint manufacturing agreement for PET and medical imaging devices | 2022-02-03 | View |
| Streeterville Capital, LLC | — | investor | Purchaser of the Convertible Promissory Note | 2021-08-23 | View |
| Shineco, Inc. | SISI | target | Issuer of the Convertible Promissory Note | 2021-08-23 | View |
| Ankang Longevity Pharmaceutical (Group) Co., Ltd. | — | target | Target company acquired by Tenet-Jove in a restructuring agreement. | 2021-08-16 | View |
| Yushe County Guangyuan Forest Development Co., Ltd. | — | acquirer | Company acquired by Tenet-Jove in exchange for Ankang Longevity equity. | 2021-08-16 | View |
| SHINECO, INC. | SISI | target | Issuer of the Convertible Promissory Note | 2021-07-21 | View |
| STREETERVILLE CAPITAL, LLC | — | investor | Purchaser of the Convertible Promissory Note | 2021-07-21 | View |
| Shineco Inc. | TYHT | acquirer | Listed company executing restructuring to acquire assets from Guangyuan and divest Ankang. | 2021-06-11 | View |
| Beijing Tenet Jove Technological Development Co., Ltd. | — | partner | Wholly-owned subsidiary of Shineco Inc. acting as a party to the restructuring and VIE agreements. | 2021-06-11 | View |
| Ankang Changshou Pharmaceutical Group | — | target | Company being divested from Shineco Inc. as part of the restructuring. | 2021-06-11 | View |
| Yushe County Guangyuan Forest Development Co., Ltd. | — | target | Company whose assets are being merged into Shineco Inc. in exchange for divested Ankang assets. | 2021-06-11 | View |
| Chengdu Zhongteng Fortune Industrial Co., Ltd. | — | partner | Company that signed a Cooperation Intent Agreement with Guangyuan, relevant to restructuring conditions. | 2021-06-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2025-10-08 | Notice of Delisting or Transfer; Other Events | View | |
| 2025-07-31 | Notice of Delisting or Transfer; Other Events | View | |
| 2025-07-09 | Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits | View | |
| 2025-06-30 | Financial Statements and Exhibits | View | |
| 2025-06-23 | Notice of Delisting or Transfer | View | |
| 2025-06-23 | Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Other E | Acquisition | View |
| 2025-06-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-02 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-05-15 | Financial Statements and Exhibits | View | |
| 2025-05-13 | Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Other E | Acquisition | View |
| 2025-04-23 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-03-20 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-12-30 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2024-12-09 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-12-04 | Notice of Delisting or Transfer | View | |
| 2024-11-12 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-11-08 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2024-10-25 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2024-09-18 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2024-09-13 | Notice of Delisting or Transfer | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR